Summary by Futu AI
Kathryn E Wengel, EVP, Chief TO and Risk Officer at Johnson & Johnson, was involved in a transaction with the company's stock on February 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. This information is essential for investors to understand the implications of the transaction on their investment decisions.